(Q45885107)

17 December 2017

title

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

hemophilia B

0 references

author name string

M V Ragni

1

1 reference

17 December 2017

K J Pasi

2

1 reference

17 December 2017

G C White

3

1 reference

17 December 2017

P L Giangrande

4

1 reference

17 December 2017

S G Courter

5

1 reference

17 December 2017

K L Tubridy

6

1 reference

17 December 2017

Recombinant FIX Surgical Study Group

7

1 reference

17 December 2017

publication date

1 March 2002

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

91-97

1 reference

17 December 2017

Molecular cloning of the gene for human anti-haemophilic factor IX.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Isolation and characterization of a cDNA coding for human factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Immune hemolysis by isohemagglutinins in factor IX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Parvovirus B19 infection in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Immunosuppressive effects of factor IX products: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Recombinant factor IX (BeneFix) by adjusted continuous infusion: a study of stability, sterility and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

Factor IX inhibitors and anaphylaxis in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00587.X

10.1046/J.1365-2516.2002.00587.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017